glp-1 small molecule Orforglipron FDA Approval: Why the First Small-Molecule Pill Matters BioWorld

Today, we unpack Marty Makarys Senate confirmation hearing, see a new ruling against GLP-1 compounders, examine the effects of the NIH patent freeze, and explore the tumultuous biotech job market

The oral granule capsuleswhich come in 40 mg, 60 mg and 80 mg dosesare intended to be opened and sprinkled on soft foods prior to administration

As you sleep, the time-released nutrients re-texturize your skin, so you wake up to a firmer, smoother, and more luminous complexion

HydraFacial gently removes dead skin cells and unclogs pores without causing irritation, making it suitable for sensitive skin prone to rosacea flare-ups